Immediate Effects of Ankle Joint Mobilization on Jump Performance in Healthy University Students
Immediate Effects of Ankle Joint Mobilization on Countermovement Jump Performance and Dorsiflexion Range of Motion in Healthy University Students
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
Vertical jump performance is an important indicator of lower-extremity explosive power and neuromuscular function. Adequate ankle dorsiflexion range of motion plays a critical role in force production, movement efficiency, and landing mechanics during jumping tasks. Previous studies have demonstrated that ankle joint mobilization can improve dorsiflexion range of motion through mechanical and neurophysiological mechanisms. However, limited evidence exists regarding whether these immediate improvements in ankle mobility translate into enhanced jump performance in healthy individuals.
This randomized controlled study aims to evaluate the immediate effects of ankle joint mobilization on countermovement jump performance and ankle dorsiflexion range of motion in healthy university students.
Approximately 50 healthy university students will be recruited and randomly allocated to either an ankle joint mobilization group or a sham mobilization group (25 participants per group). Before the intervention, all participants will undergo assessments of countermovement jump performance using the My Jump Lab mobile application and ankle dorsiflexion range of motion using the weight-bearing lunge test with a digital inclinometer.
Participants in the intervention group will receive ankle joint mobilization using the Mobilization with Movement (MWM) technique. Participants in the sham group will be positioned similarly and perform the same movement without the application of therapeutic posterior talar glide. Immediately after the intervention, all outcome measures will be repeated using the same standardized procedures.
The primary outcome will be countermovement jump performance, while the secondary outcome will be ankle dorsiflexion range of motion. The results of this study may provide evidence regarding the immediate effects of ankle joint mobilization on functional performance and may contribute to the development of evidence-based manual therapy interventions for improving lower-extremity performance
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Burhan Taşkaya, PhD
- Telefonnummer: 2449 +904364364949
- E-Mail: b.taskaya@alparslan.edu.tr
Studienorte
-
-
Muş
-
Muş, Muş, Türkei (türkiye), 49250
- Muş Alparslan University, Vocational School of Health Services
-
Kontakt:
- Burhan Taşkaya, PhD
- Telefonnummer: +905052350030
- E-Mail: b.taskaya@alparslan.edu.tr
-
Hauptermittler:
- Burhan Taşkaya, PhD
-
Unterermittler:
- Cengiz Taşkaya, PhD
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Healthy university students aged 18-30 years.
- Willing to participate and provide written informed consent.
- No history of lower extremity musculoskeletal injury or surgery within the -previous 6 months.
- No neurological or vestibular disorders affecting balance or movement.
- No contraindications to manual therapy.
Exclusion Criteria:
- Current pain in the lower extremity or spine.
- History of ankle fracture or surgery.
- Acute lower extremity injury within the previous 6 months.
- Any systemic, neurological, or rheumatological disease affecting movement.
- Participation in another intervention study during the study period.
- Inability to complete the assessment procedures.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Mobilization with Movement (MWM)
Participants assigned to this group will receive ankle joint mobilization using the Mobilization with Movement (MWM) technique.
A sustained posterior talar glide will be applied while participants actively perform a weight-bearing lunge movement.
The intervention will consist of three sets of ten repetitions, with a 2-3 second hold at the end range of each repetition.
|
A Mulligan Mobilization with Movement technique will be applied to the talocrural joint.
During active weight-bearing lunge movement, a sustained posterior talar glide will be applied by the therapist.
The intervention will consist of three sets of ten repetitions.
|
|
Schein-Komparator: Sham Mobilization
Participants assigned to this group will undergo the same positioning and active weight-bearing lunge movement as the experimental group.
However, no therapeutic posterior talar glide will be applied.
This procedure is designed to mimic the intervention without providing a therapeutic mobilization effect.
|
Participants will perform the same active movement in the same position as the experimental group.
The therapist will maintain hand contact without applying a therapeutic posterior talar glide.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Countermovement Jump Performance
Zeitfenster: Immediately before the intervention and immediately after the intervention (single session).
|
Countermovement jump (CMJ) performance will be assessed using the My Jump Lab mobile application.
Participants will perform three maximal countermovement jumps with their hands on their hips, and the highest jump height (cm) will be recorded.
|
Immediately before the intervention and immediately after the intervention (single session).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Ankle Dorsiflexion Range of Motion
Zeitfenster: Immediately before the intervention and immediately after the intervention (single session)
|
Ankle dorsiflexion range of motion will be measured using the weight-bearing lunge test with a digital inclinometer.
Three measurements will be obtained, and the average value (degrees) will be used for analysis.
|
Immediately before the intervention and immediately after the intervention (single session)
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Burhan Taşkaya, Muş Alparslan University
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Vicenzino B, Branjerdporn M, Teys P, Jordan K. Initial changes in posterior talar glide and dorsiflexion of the ankle after mobilization with movement in individuals with recurrent ankle sprain. J Orthop Sports Phys Ther. 2006 Jul;36(7):464-71. doi: 10.2519/jospt.2006.2265.
- Blatter J, Brehm JM, Sordillo J, Forno E, Boutaoui N, Acosta-Perez E, Alvarez M, Colon-Semidey A, Weiss ST, Litonjua AA, Canino G, Celedon JC. Folate Deficiency, Atopy, and Severe Asthma Exacerbations in Puerto Rican Children. Ann Am Thorac Soc. 2016 Feb;13(2):223-30. doi: 10.1513/AnnalsATS.201508-549OC.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 12.05.2026-247343
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .